Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3ERN

Crystal structure of 2C-methyl-D-erythritol 2,4-clycodiphosphate synthase complexed with AraCMP

Summary for 3ERN
Entry DOI10.2210/pdb3ern/pdb
Descriptor2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase, ZINC ION, CYTOSINE ARABINOSE-5'-PHOSPHATE, ... (6 entities in total)
Functional Keywordsmecdp-synthase, isoprene biosynthesis, lyase, magnesium, manganese, metal-binding
Biological sourceEscherichia coli K-12
Total number of polymer chains6
Total formula weight108155.82
Authors
Hunter, W.N.,Ramsden, N.L.,Kemp, L.A. (deposition date: 2008-10-02, release date: 2009-08-25, Last modification date: 2023-11-01)
Primary citationRamsden, N.L.,Buetow, L.,Dawson, A.,Kemp, L.A.,Ulaganathan, V.,Brenk, R.,Klebe, G.,Hunter, W.N.
A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy
J.Med.Chem., 52:2531-2542, 2009
Cited by
PubMed Abstract: The nonmevalonate route to isoprenoid biosynthesis is essential in Gram-negative bacteria and apicomplexan parasites. The enzymes of this pathway are absent from mammals, contributing to their appeal as chemotherapeutic targets. One enzyme, 2C-methyl-d-erythritol-2,4-cyclodiphosphate synthase (IspF), has been validated as a target by genetic approaches in bacteria. Virtual screening against Escherichia coli IspF (EcIspF) was performed by combining a hierarchical filtering methodology with molecular docking. Docked compounds were inspected and 10 selected for experimental validation. A surface plasmon resonance assay was developed and two weak ligands identified. Crystal structures of EcIspF complexes were determined to support rational ligand development. Cytosine analogues and Zn(2+)-binding moieties were characterized. One of the putative Zn(2+)-binding compounds gave the lowest measured K(D) to date (1.92 +/- 0.18 muM). These data provide a framework for the development of IspF inhibitors to generate lead compounds of therapeutic potential against microbial pathogens.
PubMed: 19320487
DOI: 10.1021/jm801475n
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon